CM
ROIV icon

Caption Management’s Roivant Sciences ROIV Stock Holding History

Caption Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.09M Buy
219,800
+58,813
+37% +$1.51M 0.04% 475
2025
Q4 		$3.49M Buy
+160,987
New +$3.18M 0.02% 628
2025
Q3 		– Sell
-256,661
Closed -$3.18M – 1985
2025
Q2 		$2.89M Hold
256,661
– – 0.03% 596
2025
Q1 		$2.59M Buy
256,661
+106,323
+71% +$1.15M 0.02% 602
2024
Q4 		$1.78M Sell
150,338
-19,662
-12% -$232K 0.02% 731
2024
Q3 		$1.96M Buy
170,000
+45,670
+37% +$520K 0.03% 565
2024
Q2 		$1.31M Buy
+124,330
New +$1.36M 0.02% 587
2023
Q4 		– Sell
-40,000
Closed -$390K – 1618
2023
Q3 		$467K Buy
+40,000
New +$452K 0.01% 946

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Caption Management's ROIV Position: Q1 2026 in Review

Caption Management increased its Roivant Sciences (ROIV) stake by 37% in Q1 2026, buying an estimated $1.51M and bringing the position to 219,800 shares worth $6.09M. The position accounts for 0.04% of the portfolio, ranked #475.

Caption Management first reported a position in ROIV in Q3 2023 and has held it in 8 quarters since. 440 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • Caption Management held 219,800 shares of Roivant Sciences worth $6.09M as of Q1 2026.
  • Caption Management bought 58,813 Roivant Sciences shares in Q1 2026, an estimated $1.51M.
  • Roivant Sciences made up 0.04% of Caption Management's portfolio in Q1 2026, its #475 holding.
  • Caption Management first reported a position in Roivant Sciences in Q3 2023 and has held it in 8 quarters since.
  • 440 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.